| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 7.260 | 18.335 | 30.946 | 62.600 | 187.837 | 223.320 |
| Total Income - EUR | - | - | - | - | 7.260 | 18.335 | 30.946 | 62.600 | 199.162 | 226.819 |
| Total Expenses - EUR | - | - | - | - | 12.408 | 22.329 | 37.542 | 124.080 | 93.047 | 97.030 |
| Gross Profit/Loss - EUR | - | - | - | - | -5.148 | -3.994 | -6.596 | -61.480 | 106.115 | 129.789 |
| Net Profit/Loss - EUR | - | - | - | - | -5.366 | -4.525 | -7.525 | -62.880 | 104.146 | 122.986 |
| Employees | - | - | - | - | 0 | 0 | 0 | 1 | 2 | 2 |
Check the financial reports for the company - Dr. Obada S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 62.004 | 232.127 | 220.097 | 200.060 | 208.507 |
| Current Assets | - | - | - | - | 7.351 | 1.651 | 8.033 | 16.589 | 24.393 | 153.254 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 1.250 | 736 | 1.057 |
| Receivables | - | - | - | - | 10 | 248 | 243 | 12.821 | 13.829 | 11.713 |
| Cash | - | - | - | - | 7.341 | 1.403 | 7.790 | 2.518 | 9.828 | 140.484 |
| Shareholders Funds | - | - | - | - | -5.324 | -9.748 | -17.056 | -79.989 | 24.400 | 147.249 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 12.675 | 73.402 | 257.216 | 316.675 | 200.054 | 214.512 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dr. Obada S.r.l.